MasTec, Inc. (MTZ) Reports In-Line Q2 EPS; Guides Q3, FY14
Get Alerts MTZ Hot Sheet
Price: $286.11 +1.78%
Financial Fact:
Diluted net income per share attributable to MasTec: 0.69
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Diluted net income per share attributable to MasTec: 0.69
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
MasTec, Inc. (NYSE: MTZ) reported Q2 EPS of $0.40, in-line with the analyst estimate of $0.40. Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.09 billion.
MasTec, Inc. sees FY2014 EPS of $1.55-$1.58, versus the consensus of $1.82. MasTec, Inc. sees FY2014 revenue of $4.4-4.5 billion, versus the consensus of $4.54 billion.
MasTec, Inc. sees Q3 2014 EPS of $0.56, versus the consensus of $0.61. MasTec, Inc. sees Q3 2014 revenue of $1.30-1.35 billion, versus the consensus of $1.26 billion.
For earnings history and earnings-related data on MasTec, Inc. (MTZ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
- Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share